INOVIO Wins $80.4 Million Judgment in VGXI/GeneOne Case
INOVIO secured a $80.4 million judgment, including $61.8 million in damages and $18.7 million in fees. The company warned that the defendants’ financial condition will likely impair collection.
INOVIO obtained an $80.4M judgment against VGXI and GeneOne, comprising $61.8M in damages and $18.7M in fees. The company cautioned that the defendants’ financial condition will likely hinder collection.